US Patent 7897567 Methods of protecting against radiation damage using alpha thymosin
Patent 7897567 was granted and assigned to SciClone Pharmaceuticals on March, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+139 characters)
Article
Patent abstract
Damage to cells and/or a subject caused by radiation is treated or prevented by administration of an alpha thymosin peptide.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Alfred R. Rudolph0
Cynthia W. Tuthill0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07897567 Methods of protecting against radiation damage using alpha thymosin US Patent 7897567 Methods of protecting against radiation damage using alpha thymosin
Infobox
Patent Number
078975670
Patent Number
78975670
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078975670
Date of Patent
March 1, 2011
0Patent Application Number
105358350
Date Filed
November 25, 2003
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07897567 Methods of protecting against radiation damage using alpha thymosin
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07897567
Date of patent
March 1, 2011
Patent application number
10535835
Date Filed
November 25, 2003
Patent primary examiner
Find more entities like US Patent 7897567 Methods of protecting against radiation damage using alpha thymosin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
